|
US2490813A
(en)
|
1944-11-29 |
1949-12-13 |
Standard Oil Co |
Continuous process for making aryl amines
|
|
US3299078A
(en)
|
1962-10-01 |
1967-01-17 |
Smith Kline French Lab |
Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
|
|
US3813392A
(en)
|
1969-06-09 |
1974-05-28 |
J Sellstedt |
Pyrrolo(1,2,3-alpha epsilon)quinoxalin-2(3h)-ones and related compounds
|
|
US4238607A
(en)
|
1972-06-19 |
1980-12-09 |
Endo Laboratories Inc. |
Pyridopyrrolo benzheterocycles
|
|
US3914421A
(en)
|
1972-06-19 |
1975-10-21 |
Endo Lab |
Pyridopyrrolobenzheterocycles for combatting depression
|
|
US4115577A
(en)
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4183936A
(en)
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4219550A
(en)
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
|
US4522944A
(en)
|
1982-12-23 |
1985-06-11 |
Erba Farmitalia |
Carboxamido-derivatives of 5H-1,3,4-thiadiazolo[3,2-a]pyrimidines, compositions and use
|
|
EP0238059B1
(en)
|
1986-03-19 |
1993-06-16 |
Kumiai Chemical Industry Co., Ltd. |
5H-1,3,4-Thiazole[3,2-a]pyrimidin-5-one derivatives and fungicidal compositions containing the same
|
|
JP2641443B2
(ja)
|
1986-04-07 |
1997-08-13 |
クミアイ化学工業株式会社 |
５Ｈ−１，３，４−チアジアゾロ〔３，２−ａ〕ピリミジン−５−オン誘導体及びこれを有効成分とする農園芸用殺菌剤
|
|
HU208484B
(en)
|
1988-08-17 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
|
|
US5114976A
(en)
|
1989-01-06 |
1992-05-19 |
Norden Michael J |
Method for treating certain psychiatric disorders and certain psychiatric symptoms
|
|
US5576460A
(en)
|
1994-07-27 |
1996-11-19 |
Massachusetts Institute Of Technology |
Preparation of arylamines
|
|
US5648539A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Low temperature arylamine processes
|
|
US5648542A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Arylamine processes
|
|
US5654482A
(en)
|
1996-02-29 |
1997-08-05 |
Xerox Corporation |
Triarylamine processes
|
|
US5847166A
(en)
|
1996-10-10 |
1998-12-08 |
Massachusetts Institute Of Technology |
Synthesis of aryl ethers
|
|
US5723671A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
|
US5705697A
(en)
|
1997-01-30 |
1998-01-06 |
Xerox Corporation |
Arylamine processes
|
|
US5723669A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
|
US6323366B1
(en)
|
1997-07-29 |
2001-11-27 |
Massachusetts Institute Of Technology |
Arylamine synthesis
|
|
GB2328686B
(en)
|
1997-08-25 |
2001-09-26 |
Sankio Chemical Co Ltd |
Method for producing arylamine
|
|
US6395939B1
(en)
|
1997-10-06 |
2002-05-28 |
Massachusetts Institute Of Technology |
Diaryl ether condensation reactions
|
|
US6235936B1
(en)
|
1998-02-26 |
2001-05-22 |
Massachusetts Institute Of Technology |
Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates
|
|
JP4647780B2
(ja)
|
1998-02-26 |
2011-03-09 |
マサチューセッツ インスティテュート オブ テクノロジー |
ヒドラジン、ヒドラゾン、ヒドロキシルアミンおよびオキシムの金属−触媒アリール化およびビニル化
|
|
US5902901A
(en)
|
1998-05-07 |
1999-05-11 |
Xerox Corporation |
Arylamine processes
|
|
US6307087B1
(en)
|
1998-07-10 |
2001-10-23 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
|
US7223879B2
(en)
|
1998-07-10 |
2007-05-29 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
|
US6395916B1
(en)
|
1998-07-10 |
2002-05-28 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
|
CA2336691C
(en)
|
1998-07-10 |
2009-02-10 |
Massachusetts Institute Of Technology |
Ligands for metals and metal-catalyzed processes
|
|
US20010008942A1
(en)
|
1998-12-08 |
2001-07-19 |
Buchwald Stephen L. |
Synthesis of aryl ethers
|
|
US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
|
PE20010052A1
(es)
|
1999-04-23 |
2001-01-27 |
Upjohn Co |
Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
US6548493B1
(en)
|
1999-06-15 |
2003-04-15 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
US6541639B2
(en)
|
2000-07-26 |
2003-04-01 |
Bristol-Myers Squibb Pharma Company |
Efficient ligand-mediated Ullmann coupling of anilines and azoles
|
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
BR0116429A
(pt)
|
2000-12-20 |
2006-05-09 |
Bristol Myers Squibb Co |
piridoindóis substituìdos como agonistas e antagonistas da serotonina
|
|
EP2272813B1
(en)
|
2001-04-24 |
2016-11-16 |
Massachusetts Institute of Technology (MIT) |
Copper-catalyzed formation of carbon-oxygen bonds
|
|
KR20050032107A
(ko)
|
2002-08-02 |
2005-04-06 |
메사추세츠 인스티튜트 오브 테크놀로지 |
구리를 촉매로 한 탄소-헤테로원자 결합 및 탄소-탄소결합 형성방법
|
|
US7223870B2
(en)
|
2002-11-01 |
2007-05-29 |
Pfizer Inc. |
Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
|
|
WO2004056324A2
(en)
|
2002-12-19 |
2004-07-08 |
Bristol-Myers Squibb Company |
Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
|
|
MXPA06000725A
(es)
|
2003-07-21 |
2006-03-30 |
Smithkline Beecham Corp |
Sal de acido (2s-4s)-4 -fluoro-1 -[4-fluoro- beta-(4- fluorofenil) -l-fenilalanil] -2-pirrolidincarbonitril p-toluenosulfonico y formas cristalinas anhidras del mismo.
|
|
US7109064B2
(en)
|
2003-12-08 |
2006-09-19 |
Semiconductor Components Industries, L.L.C. |
Method of forming a semiconductor package and leadframe therefor
|
|
JP2005259113A
(ja)
|
2004-02-12 |
2005-09-22 |
Ricoh Co Ltd |
プロセス編集装置、プロセス管理装置、プロセス編集プログラム、プロセス管理プログラム、記録媒体、プロセス編集方法及びプロセス管理方法
|
|
US20050222209A1
(en)
|
2004-04-01 |
2005-10-06 |
Zeldis Jerome B |
Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
|
|
US7592454B2
(en)
|
2004-04-14 |
2009-09-22 |
Bristol-Myers Squibb Company |
Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
|
|
BRPI0519054A2
(pt)
|
2004-12-15 |
2008-12-23 |
Hoffmann La Roche |
fenil metanonas bi e tricÍclicas substituÍdas como inibidores de transportador i de glicina (glyt-1) para o tratamento de doenÇa de alzheimer
|
|
KR20070099031A
(ko)
|
2005-01-25 |
2007-10-08 |
셀진 코포레이션 |
4-아미노-2-(3-메틸-2,6-디옥소피페리딘-3-일)-이소인돌-1,3-디온을 사용한 방법 및 조성물
|
|
EP1919287A4
(en)
|
2005-08-23 |
2010-04-28 |
Intra Cellular Therapies Inc |
ORGANIC COMPOUNDS FOR TREATING A REDUCED DOPAMINE RECEPTOR SIGNALING ACTIVITY
|
|
BRPI0706523A2
(pt)
|
2006-01-13 |
2011-01-04 |
Wyeth Corp |
composto de fórmula i; composição farmacêutica; método de tratamento de distúrbios que estão relacionados com ou são afetados pela inibição da recaptação de norepinefrina, o receptor de 5-ht6 ou o receptor de 5-ht2a; método de tratamento de um distúrbio de aprendizado, de um distúrbio cognitivo, de um distúrbio de memória, de um distúrbio de personalidade, de um distúrbio comportamental, de um distúrbio de movimento, de um distúrbio neurodegenerativo, de abstinência de droga, de distúrbio de sono, de um distúrbio alimentar, de uma toxicidade de droga aguda, de um distúrbio cardiovascular, de uma disfunção sexual, de um distúrbio gastrintestinal, de um distúrbio genitourinário, de um distúrbio de dor, de um distúrbio nervoso ou de um distúrbio de sintoma vasomotor; método de tratamento de doença de alzheimer, de um distúrbio de deficiência da atenção, de esquizofrenia, de doença de parkinson, de discinésia tardia, de ataxia, de bradicinésia, de discinésias paroxìsmicas, de sìndrome da perna irrequieta, de tremor, de tremor essencial, de epilepsia, de apoplexia ou de trauma na cabeça; método de tratamento de doença arterial coronariana, de enfarte do miocárdio, de ataque isquêmico transitório, de angina, de fibrilação atrial, de agregação plaquetária, de risco de formação de coágulo sanguìneo, de sìndrome do intestino irritável, de constipação crÈnica, de doença do refluxo gastrintestinal, de dispepsia, de incontinência urinária por estresse ou de incontinência urinária de urgência; método de tratamento de depressão, de distúrbio compulsivo obsessivo, de tendência ao suicìdio, de distúrbio de ansiedade, de distúrbio bipolar, de distúrbio de pánico, de abstinência de nicotina, de abstinência de álcool, de abstinência de cocaìna, de abstinência de heroìna, de abstinência de anfetamina, de abstinência de drogas narcóticas, de insÈnia, de apnéia do sono, de narcolepsia, de distúrbio afetivo sanzonal, de sìndrome da perna irrequieta, de distúrbio de sono de turno de trabalho, de sìndrome da fase do sono retardada, de anorexia nervosa, de bulimia nervosa, de sìndrome do comer noturno, de superalimentação compulsiva, de sìndrome da fadiga crÈnica, de fibromialgia, de neuropatia de dor, de dor antinociceptiva, de sìndrome da dor crÈnica, de neuropatia diabética, de fogacho ou de suor noturno; e uso de um composto
|
|
JP2010502722A
(ja)
|
2006-09-08 |
2010-01-28 |
ブレインセルス，インコーポレイティド |
４−アシルアミノピリジン誘導体を含む組み合わせ
|
|
CN101796051B
(zh)
|
2007-03-12 |
2013-11-06 |
细胞内治疗公司 |
与取代的杂环稠合的γ-咔啉的合成
|
|
EP2175724A4
(en)
|
2007-08-01 |
2010-09-15 |
Medivation Neurology Inc |
METHOD AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA USING ANTIPSYCHOTIC COMBINATION THERAPY
|
|
CA2713935C
(en)
|
2008-02-07 |
2016-11-01 |
Schering Corporation |
Engineered anti-tslpr antibodies
|
|
PL2262505T3
(pl)
*
|
2008-03-12 |
2015-04-30 |
Intra Cellular Therapies Inc |
Podstawione heterocykliczne skondensowane gamma-karboliny w postaci stałej
|
|
CN105168219B
(zh)
*
|
2008-05-27 |
2018-11-20 |
细胞内治疗公司 |
用于睡眠障碍和其他疾病的方法和组合物
|
|
MX339805B
(es)
*
|
2010-04-22 |
2016-06-10 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
|
MX2014012374A
(es)
|
2012-04-14 |
2015-04-17 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
|
WO2014145192A1
(en)
|
2013-03-15 |
2014-09-18 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
EP3076967B1
(en)
|
2013-12-03 |
2021-07-28 |
Intra-Cellular Therapies, Inc. |
Methods for treating residual symptoms of schizophrenia
|
|
US10077267B2
(en)
|
2014-04-04 |
2018-09-18 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
MX387784B
(es)
*
|
2017-03-24 |
2025-03-18 |
Intra Celular Therapies Inc |
Composiciones novedosas y metodos.
|